IMIBIC Logo
IMIBIC Logo
Grupo de investigación

GC27 OncObesidad y Metabolismo

Activos en 2023

A multicenter, doubled-blind, multidose, placebo controlled, rtandomized, parallel group, phase 2 study to evaluate the efficacy and safety of intravenous protocol BII093 for patients with brain contusion

IP: JUAN SOLIVERA VELA

Prevención del ICTUS en supervivientes de hemorragia intracerebral con fibrilación auricular (PRESTIGE-AF)

IP: ROBERTO VALVERDE MOYANO

Activos en 2022

Prevención del ICTUS en supervivientes de hemorragia intracerebral con fibrilación auricular (PRESTIGE-AF)

IP: DR. ROBERTO VALVERDE MOYANO

A multicenter, doubled-blind, multidose, placebo controlled, rtandomized, parallel group, phase 2 study to evaluate the efficacy and safety of intravenous protocol BII093 for patients with brain contusion

IP: DR. JUAN SOLIVERA VELA

Fibrilación Auricular No Tratada en Andalucía: Screening Tras el Ictus (FANTASTIC)

IP: DR. ROBERTO VALVERDE MOYANO

Optimal detection of atrial fibrillation in transient ischemic attack

IP: DR. ROBERTO VALVERDE MOYANO

Swiss trial of decomnpre4ssive craniectomy versus best medical treatment of spontaneous upratentorial ntracerebralhemorrhage (SWITCH): a randomized controlled trial

IP: DR. JUAN SOLIVERA VELA